Cancer Journal

Article	Citations
Human Papillomavirus–Directed Therapeutics for Human Papillomavirus–Associated Oropharyngeal Cancer	49
Theranostics in Neuroendocrine Tumors	41
Hepatocellular Carcinoma Genetic Classification	31
Improving Equity in Cancer Care in the Face of a Public Health Emergency	19
Adoptive Cell Therapy for Advanced Solid Tumors	18
Concerns About Compounded Bioidentical Menopausal Hormone Therapy	15
Beyond the COVID-19 Pandemic	14
Is There a Role for Cellular Therapy in Chronic Lymphocytic Leukemia?	14
Menopausal Hormone Therapy and Breast Cancer	14
Poly(ADP-Ribose) Polymerase Inhibition in Small Cell Lung Cancer	14
Autoimmune Cytopenia in CLL	13
Circulating Biomarkers in Glioblastoma	13
Cell Cycle Checkpoints p16 and p21—Strong Predictors of Clinicopathologic Outcomes in High-Grade Osteosarcoma	12
Minimal Residual Disease in Multiple Myeloma	12
The Clinical Challenges, Trials, and Errors of Combatting Poly(ADP-Ribose) Polymerase Inhibitors Resistance	11
New Roles of Poly(ADP-Ribose) Polymerase Inhibitors in the Treatment of Breast Cancer	11
The Clinical Value of Plasma Epstein-Barr Virus DNA as a Tumor Marker in Nasopharyngeal Carcinoma: Prognostic? Yes, But How Can We Best Use It?	11
Oncology Physician Workforce Diversity	10
The Potential for Selective Cyclin-Dependent Kinase 4/6 Inhibition in the Therapy for Head and Neck Squamous Cell Carcinoma	10
Is There a Current Role for Combination Chemotherapy or High-Dose Interleukin 2 in Melanoma?	9
Disparities in Gynecologic Cancers	9
PET Imaging of Metabolism, Perfusion, and Hypoxia	8
Hepatocellular Carcinoma—Southeast Asia Updates	7
HER2 and HER3 as Therapeutic Targets in Head and Neck Cancer	7
Microbiome and Diet in Colon Cancer Development and Treatment	7

Supportive Care for Patients With Myelodysplastic Syndromes	7
Toxicities From Antibody-Drug Conjugates	7
Chimeric Antigen Receptor T-Cell Therapy	7
Social Drivers of Cancer Risk and Outcomes Among African American Men	7
Updates in Classification of Myelodysplastic Syndrome	7
Evolution of Response-Based Radiotherapy for Hepatocellular Cancer	7
Targeting Epidermal Growth Factor Receptor in Head and Neck Cancer	7
New Metabolomic Insights Into Cancer	6
Radiopharmaceuticals for Cancer Diagnosis and Therapy	6
Mechanistic Effects of Estrogens on Breast Cancer	6
Impact of Precision Medicine in Oncology	6
Epidemiology and Pathogenesis of Myelodysplastic Syndrome	6
Ecosystemic Approach to Understanding Gut Microbiome–Mediated Prevention of Colorectal Cancer	6
Radiation Therapy and the Microbiome; More Than a Gut Feeling	6
From Bench to Bedside	6
The Current Role of Human Papillomavirus Circulating Tumor DNA in Oropharynx Cancer	6
Treatment of Locally Recurrent Rectal Cancer	6
Effective Personalization of Stereotactic Radiosurgery for Brain Metastases in the Modern Era	6
Introduction	6
Poly(ADP-Ribose) Polymerase Inhibitor Inhibition in Ovarian Cancer	6
Digital Health for Oncological Care	6
Local and Systemic Management Options for Melanoma Brain Metastases	5
Targeting HRAS in Head and Neck Cancer	5
Building a Bridge to Equity in Health and Health Care in Cancer Care	5
Myelodysplastic Syndromes/Neoplasms—Insights Into Pathogenesis Leading to Improved Classification, Risk Stratification, and Treatments	5
Telehealth and Technology	5
Circulating Tumor DNA in Human Papillomavirus–Mediated Oropharynx Cancer	5
Individualizing Therapy for Malignant Gliomas	5
Health Care Policy and Disparities in Health	5
A General Approach to Patients Presenting With Locally Advanced or Distant Metastatic Disease	5
The Evolution of Research and Therapy With Hypomethylating Agents in Acute Myeloid Leukemia and Myelodysplastic Syndrome: New Directions for Old Drugs	5
Telehealth in Cancer Care	5
How Far We’ve Come	5
Introduction Chronic Lymphocytic Leukemia. Where Do We Stand, Where Do We Go	4
Evolving Landscape of Antibody Drug Conjugates in Lymphoma	4
Role of the Microbiome in Immunotherapy of Melanoma	4
Short- and Long-term Repercussions of Vancomycin on Immune Surveillance and the Efficacy of Antitumor Treatments	4
An Overview of Organoid and 3-Dimensional Models in Multiple Myeloma	4
Clinical Evidence Generation During a Pandemic	4
Management of Chronic Lymphocytic Leukemia in Less-Resourced Countries	4
Evolution of Therapy for Older Patients With Acute Myeloid Leukemia	4
Adoptive Cellular Therapy for Pediatric Solid Tumors: Beyond Chimeric Antigen Receptor-T Cell Therapy	4
Novel Approaches and Future Directions in Myelodysplastic Syndrome Treatment	3
Discovery of Natural Products for Cancer Prevention	3
Menin Inhibitors in Acute Myeloid Leukemia—What Does the Future Hold?	3
The Principles and Practice of PARP Inhibitor Therapy	3
The Challenges and Future of Immunotherapy for Gliomas	3
Hormone Replacement Therapy After Breast Cancer	3
From Race to Racism and Disparities to Equity	3
Neurosurgical Advances for Malignant Gliomas	3

PARP Inhibitors in Pancreatic Cancer	3
Current State of Cell Therapies for Breast Cancer	3
Natural Killer Cell Recognition and Control of Epithelial Cancers	3
Therapeutic Response Assessment of High-Grade Gliomas During Early-Phase Drug Development in the Era of Molecular and Immunotherapies	3
Measurable Residual Disease Assessment as a Surrogate Marker in New Drug Development in Acute Myeloid Leukemia	3
Introduction	3
PI3K Inhibition for Squamous Cell Head and Neck Carcinoma	3
Telemedicine and cancer care: Barriers and strategies to optimize delivery: Erratum	3
Combining Isocitrate Dehydrogenase Inhibitors With Existing Regimens in Acute Myeloid Leukemia	3
Stereotactic Body Radiotherapy in Oligomestatic/Oligoprogressive Sarcoma	3
Chimeric Antigen Receptor T-Cell Therapeutics for Multiple Myeloma	3
Integrated, Integral, and Exploratory Biomarkers in the Development of Poly(ADP-Ribose) Polymerase Inhibitors	3
Advancements in Understanding and Preventing Obesity-Related Colon Cancer	3
Management of Low-Grade Gliomas	3
Transcription Factors and Cancer	2
Checkpoint Inhibitors and Other Immune-Based Therapies in Acute Myeloid Leukemia	2
The Management of Low-Risk Myelodysplastic Syndromes—Current Standards and Recent Advances	2
Current State of Stereotactic Body Radiation Therapy for Genitourinary Malignancies	2
Overexpression of glyoxalase system enzymes in human kidney tumor: Erratum	2
Surgical Considerations for Tumor Tissue Procurement to Obtain Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy	2
Emerging Challenges to Cellular Therapy of Cancer	2
Nuclear Medicine Cancer Care—Current Status and Future Directions for Radiopharmaceutical Diagnostics and Theranostics for Cancer	2
Positron Emission Tomography Imaging of Tumor Proliferation and DNA Repair	2
The Utility of Interim Positron Emission Tomography Imaging to Inform Adaptive Radiotherapy for Head and Neck Squamous Cell Carcinoma	2
Effective Image Communication of Hormone Replacement Therapy Risks and Benefits	2
c-Met Signaling as a Therapeutic Target in Head and Neck Cancer	2
The Evolving Molecular Landscape of High-Grade Gliomas	2
Stereotactic Body Radiation Therapy	2
Nonoperative Management for Rectal Cancer	2
Current State of Cell Therapies for Genitourinary Malignancies	2
Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer	2
Telemedicine and Cancer Clinical Research	2
Investigational Approaches for Treatment of Melanoma Patients Progressing After Standard of Care	2
Integrating Targeted Therapies in the Management of Head and Neck Cancers	2
Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms	2
Melanoma—Modern Treatment for Metastatic Melanoma	2
Telemedicine Across the Cancer Care Continuum	2
Estrogen for the Treatment and Prevention of Breast Cancer	2
The Evolving Role of Stereotactic Body Radiation Therapy in Personalized Oncologic Care	2
Aurora Kinases as Therapeutic Targets in Head and Neck Cancer	2
Development of Next-Generation Poly(ADP-Ribose) Polymerase 1–Selective Inhibitors	2
What Role Does Radiotherapy Play in the Molecular Era for Intrahepatic Cholangiocarcinoma?	2
Evaluation of the Prognostic Role of Liver Metastases on Patient Outcomes	2
Survival of the Fittest	2
γδ T Cell–Based Adoptive Cell Therapies Against Solid Epithelial Tumors	1
Gene Expression Profiles in Cancers and Their Therapeutic Implications	1
Menopause Hormone Therapy in the Management of Postmenopausal Osteoporosis	1
Molecular Imaging of Steroid Receptors in Breast Cancer	1
A Brief Overview of Cancer Vaccines	1
Circulating Plasma Epstein-Barr Virus DNA Load During the Follow-up Periods Predicts Recurrence and Metastasis in Nasopharyngeal Carcinoma	1
Preclinical In Vitro and In Vivo Models for Adoptive Cell Therapy of Cancer	1
Treatment of Stage III Resectable Melanoma—Adjuvant and Neoadjuvant Approaches	1
The Lung Microbiome in Carcinogenesis and Immunotherapy Treatment	1
Fecal Microbiota Transplantation as a Cancer Therapeutic	1
Optimal Management of Chronic Lymphocytic Leukemia and Economic Constraints	1
Smoldering Myeloma Treatment	1
The Evolving Role of Allogeneic Stem Cell Transplant in the Era of Molecularly Targeted Agents	1
The Human Microbiome and Cancer	1
Tumor-Infiltrating Lymphocyte and Other Cell Therapies for Metastatic Melanoma	1
STING Agonists in Head and Neck Squamous Cell Carcinoma	1
Germline Predisposition to Myelodysplastic Syndromes	1
What Is the Timing and Role of Targeted Therapy in Metastatic Melanoma?	1
Antibody Drug Conjugates in Multiple Myeloma	1
Metastatic Melanoma Treatment in Special Populations	1
Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy	1
Primary Prevention of Cancer	1
Antibody-Drug Conjugates and Tissue-Agnostic Drug Development	1
Evolution of Therapeutic Benefit Measurement Criteria in Myelodysplastic Syndromes/Neoplasms	1
Lessons From the Impact of the COVID-19 Pandemic at the National Cancer Institute	1
PSMA-Targeted Radiopharmaceuticals for Prostate Cancer Diagnosis and Therapy	1
Updates in Risk Stratification in Myelodysplastic Syndromes	1
Prostate Cancer, Race, and Health Disparity	1
Challenges and Errors in Genetic Testing	1
Clinical Targeting of Altered Metabolism in High-Grade Glioma	1
Supportive Care for Cancer Patients Via Telehealth	1
Patterns of Enrollment in Cancer Treatment Trials During the COVID-19 Pandemic at National Cancer Institute–Designated Cancer Centers	1
Current Role and Status for Intratumoral Injection Therapies in Metastatic Melanoma	1
Multiple Myeloma	1
Diversity in Cancer Care	1
Precision Radiotherapy for Gliomas	1

The Microbiome and Liver Cancer	1
Maintenance Strategies for Myeloma	1